La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
HCA Healthcare Gestion
Gestion contrôle des critères 2/4
Le PDG HCA Healthcare's est Sam Hazen, nommé en Jan2019, a un mandat de 5.58 ans. La rémunération annuelle totale est $ 21.32M, composée du salaire de 7.1% et des bonus 92.9%, y compris les actions et options de la société. détient directement 0.51% des actions de la société, d'une valeur de $ 497.34M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 5.6 ans et 8.5 ans.
Informations clés
Sam Hazen
Directeur général
US$21.3m
Rémunération totale
| Pourcentage du salaire du PDG | 7.1% |
| Durée du mandat du directeur général | 5.6yrs |
| Propriété du PDG | 0.5% |
| Durée moyenne d'occupation des postes de direction | 5.6yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 8.5yrs |
Mises à jour récentes de la gestion
Recent updates
Results: HCA Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 26
Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 27%?
Jun 21HCA Healthcare, Inc.'s (NYSE:HCA) P/E Still Appears To Be Reasonable
Jun 06Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
May 21HCA Healthcare, Inc. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Apr 30Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong
Apr 11HCA Healthcare Is Finally At Fair Value (Rating Downgrade)
Mar 19HCA Healthcare: Improving Margins Now Reflected In Shares (Rating Downgrade)
Feb 29HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66
Feb 25HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year
Feb 05HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jan 21At US$276, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?
Jan 08HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Is Matching Sentiment Around Its Earnings
Dec 25HCA Healthcare Continues To Impress
Dec 14Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today?
Dec 11HCA Remains Attractive Despite A JV Misstep
Nov 20These 4 Measures Indicate That HCA Healthcare (NYSE:HCA) Is Using Debt Extensively
Oct 26HCA Healthcare: Rx For Success
Oct 10A Look Into HCA Healthcare's (NYSE:HCA) Impressive Returns On Capital
Oct 09HCA Healthcare: Impact Of Medicare Advantage Growth And Demographic Shift
Sep 30At US$256, Is It Time To Put HCA Healthcare, Inc. (NYSE:HCA) On Your Watch List?
Sep 17HCA Healthcare Is Beating The Industry
Sep 13Here's Why HCA Healthcare (NYSE:HCA) Can Manage Its Debt Responsibly
Jul 25HCA Healthcare (NYSE:HCA) Is Aiming To Keep Up Its Impressive Returns
Jul 10HCA Healthcare's Service Optimization And Capabilities Support Long-Run Growth
Jul 03HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 45% Above Its Share Price
Jun 25Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?
Jun 09HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 09HCA Healthcare (NYSE:HCA) Has Announced That It Will Be Increasing Its Dividend To $0.60
May 25HCA Healthcare (NYSE:HCA) Has A Pretty Healthy Balance Sheet
Apr 22HCA Healthcare (NYSE:HCA) Knows How To Allocate Capital
Apr 04Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 45%?
Mar 16At US$249, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?
Feb 26HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jan 30HCA Healthcare Q4 2022 Earnings Preview
Jan 26HCA Healthcare: An Investment For Interesting Times
Jan 13Investors Shouldn't Overlook The Favourable Returns On Capital At HCA Healthcare (NYSE:HCA)
Jan 04Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$6b |
| Mar 31 2024 | n/a | n/a | US$5b |
| Dec 31 2023 | US$21m | US$2m | US$5b |
| Sep 30 2023 | n/a | n/a | US$6b |
| Jun 30 2023 | n/a | n/a | US$6b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$15m | US$2m | US$6b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$7b |
| Mar 31 2022 | n/a | n/a | US$7b |
| Dec 31 2021 | US$21m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$5b |
| Mar 31 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$30m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$27m | US$1m | US$4b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$4b |
| Dec 31 2018 | US$10m | US$1m | US$4b |
| Sep 30 2018 | n/a | n/a | US$3b |
| Jun 30 2018 | n/a | n/a | US$3b |
| Mar 31 2018 | n/a | n/a | US$3b |
| Dec 31 2017 | US$10m | US$1m | US$2b |
Rémunération vs marché: La rémunération totale de Sam ($USD 21.32M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 13.17M ).
Rémunération et revenus: La rémunération de Sam a augmenté de plus de 20 % tandis que les bénéfices de l'entreprise ont chuté de plus de 20 % au cours de l'année écoulée.
PDG
Sam Hazen (64 yo)
5.6yrs
Titularisation
US$21,315,984
Compensation
Mr. Samuel N. Hazen, also known as Sam, serves as Director at HCA Healthcare, Inc. He serves as Chief Executive Officer of HCA Healthcare Inc. since January 01, 2019 and has been its Director since Septemb...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 5.6yrs | US$21.32m | 0.51% $ 520.5m | |
| Executive VP & COO | 1.6yrs | US$8.70m | 0.066% $ 66.5m | |
| President of American Group | 11.6yrs | US$5.40m | 0.047% $ 47.3m | |
| President of National Group | 8.1yrs | US$5.58m | 0.010% $ 10.6m | |
| Founder & Chairman Emeritus | no data | US$362.11k | 0.19% $ 188.1m | |
| CFO & Executive Vice President | less than a year | pas de données | 0.027% $ 27.4m | |
| Senior VP | 8.3yrs | pas de données | 0.016% $ 15.9m | |
| Senior VP & Chief Information Officer | less than a year | pas de données | 0.00061% $ 618.3k | |
| Executive VP and Chief Legal & Administrative Officer | 2.6yrs | US$6.47m | 0.0016% $ 1.6m | |
| Vice President of Investor Relations | 2.6yrs | pas de données | pas de données | |
| Senior VP and Chief Ethics & Compliance Officer | 5.6yrs | pas de données | 0.0037% $ 3.7m | |
| Senior Vice President of Marketing & Corporate Affairs | 6.8yrs | pas de données | 0.0014% $ 1.4m |
5.6yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Gestion expérimentée: L'équipe de direction de HCA est chevronnée et expérimentée (ancienneté moyenne 5.6 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 5.9yrs | US$21.32m | 0.51% $ 520.5m | |
| Founder & Chairman Emeritus | no data | US$362.11k | 0.19% $ 188.1m | |
| Independent Director | 6.6yrs | US$389.78k | 0% $ 0 | |
| Independent Director | 10.5yrs | US$377.95k | 0.0016% $ 1.6m | |
| Independent Director | 10.5yrs | US$334.78k | 0.0078% $ 7.9m | |
| Chairman of the Board | 18.6yrs | US$399.61k | pas de données | |
| Independent Director | 5.4yrs | US$319.78k | 0.0024% $ 2.5m | |
| Independent Director | 2.9yrs | US$339.78k | 0.0010% $ 1.0m | |
| Independent Director | 12.6yrs | US$349.78k | 0.0042% $ 4.2m | |
| Director | 15.6yrs | US$309.70k | 0.16% $ 159.4m | |
| Independent Director | 2.6yrs | US$324.78k | 0.0014% $ 1.4m | |
| Director of HealthONE | no data | pas de données | pas de données |
8.5yrs
Durée moyenne de l'emploi
65yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de HCA sont considérés comme expérimentés (ancienneté moyenne 8.5 ans).